Blood sugar checks are beneficial for those with type 2 diabetes
the ONA take:
Blood sugar self-monitoring benefits patients with type 2 diabetes even if they are not prescribed insulin, according to preliminary findings presented at the American Association of Diabetes Educators annual meeting in New Orleans, LA.
For the small study, researchers enrolled 11 patients with type 2 diabetes and worked with the patients to design personalized, structured self-monitoring blood glucose schedules.
Researchers then taught patients to react to their blood sugar level readings by performing certain interventions, such as going for a walk or eating less.
Results showed that the patients reduced their A1C levels from an average of 7.3% to 6.2% during the the study. The majority of patients received the most benefit from twice daily self-monitoring.
"Participants in this study said that sticking to a regular [self-monitoring] schedule really helped them to know where their blood levels were and take appropriate action, such as adding physical activity or choosing a healthy snack," study author Dana Brackney, a diabetes educator and an assistant professor of nursing at Appalachian State University in Boone, N.C., said.
Blood sugar self-monitoring benefits patients with type 2 diabetes even if they are not prescribed insulin.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
- Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|